TITLE

American Clinical Laboratory Association Welcomes Pathway Genomics as New Member

PUB. DATE
February 2012
SOURCE
Biomedical Market Newsletter;2/21/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article informs that Pathway Genomics Corp. has received membership in the American Clinical Laboratory Association (ACLA), non profit organization. ACLA is involved in promoting public awareness about thevalue of laboratory services in preventing illness, diagnosing disease, and monitoring medical treatment. Pathway Genomics operates an on-site genetic testing laboratory that uses scientifically validated genetic testing technologies to generate personalized genetic reports.
ACCESSION #
75197294

 

Related Articles

  • Genetic testing: current and future trends. Tsongalis, Gregory J. // MLO: Medical Laboratory Observer;Oct2006, Vol. 38 Issue 10, p42 

    The article discusses about genetic testing and its implications. The author stated that the complexities of applying such approach from inherited diseases to multifactorial diseases are a new field for the clinical laboratory. He also discussed about the current carrier-screening test for...

  • Is Genetic Testing Worth the Price? Gengler, Amanda // Money;Mar2010, Vol. 39 Issue 2, p42 

    The article questions whether home kits to analyze DNA are worth the cost. It explains the process and how to tell if a company is reputable. It suggests that people should consult their own doctor or a genetic counselor before undergoing genetic testing. Topics include insurance coverage for...

  • Beckman Genetic Tests Could Bring New Buyers. Reed, Vita // Orange County Business Journal;1/14/2008, Vol. 31 Issue 2, p3 

    The article reports that Beckman Coulter Inc. is bringing advanced genetic testing to laboratories to boost its business in the U.S. The company introduced the molecular diagnostics machine, an equipment that brings advanced genetic testing. According to Scott Garrett, chief executive of...

  • Gene testing services still in business despite Stupak's ire. McCARTY, MARK // Medical Device Daily;9/7/2010, Vol. 14 Issue 173, p1 

    The article reports that companies offering gene testing services are still in business despite the threat from Democratic Representative Bart Stupak of Michigan to shut them down. During a hearing of the House Energy and Commerce subcommittee in July 2010, Stupak revealed his plan to contact...

  • Out of control? Trivedi, Bijal // New Scientist;1/20/2007, Vol. 193 Issue 2587, p36 

    This article focuses on how genetic testing in the European Union, the U.S., Australia and Canada is under scrutiny due to companies' ability to analyze genetic samples and then issue a report. This leads to the unregulation of the sale of the testing and the advice offered, according to Stuart...

  • Industry welcomes Genetic Information Nondiscrimination Act. Allison, Malorye // Nature Biotechnology;Jun2008, Vol. 26 Issue 6, p596 

    This article discusses the Genetic Information and Nondiscrimination Act (GINA) that was signed into law on May 21, 2008 after it was passed by both the U.S. House of Representatives and Senate. The law prohibits the use of genetic information to set health insurance premiums, deny coverage or...

  • Gene testing of embryos needs guiding. Hayden, Erika Check // Nature;11/20/2008, Vol. 456 Issue 7220, p288 

    The article discusses gene testing and the technology that may be available to couples through personal genomics companies. Fertility doctors use genetic analysis to check for genetic abnormalities in embryonic cells. Parents can choose which embryos to transfer based on the results. Also...

  • Genetics police.  // Nursing Standard;8/19/2009, Vol. 23 Issue 50, p28 

    The article presents the responses of several British medical professionals who were asked whether the genetic testing industry should be regulated more tightly. The responses of Jane Brown, a clinical risk facilitator at Worcestershire Acute Hospitals NHS Trust, Brid Hehir, the head of...

  • Personal genome tests under fire in New York.  // New Scientist;4/26/2008, Vol. 198 Issue 2653, p7 

    The article reports that New York Department of Health has warned 20 genetic testing companies that they may be operating illegally. Under state law, laboratories need a state level permit to conduct analytical tests on bodily samples drawn from its citizens. Linda Avey, co-founder of 23andMe...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics